COT meeting: 28 October 2014

Agenda and papers for the meeting of the Committee at 10.00am on Tuesday, 28th October 2014 in Conference Rooms 4 & 5, Aviation House, 125 Kingsway, London WC2 6NH

Agenda

1.  Apologies for absence

2.  Draft minutes of previous meeting TOX/MIN/2014/04

3.  Matters arising

4. Recommendations of the Bystander Risk Assessment Working Group report concerning skin sensitisation from exposure to pesticides.This paper addresses the recommendations on skin sensitisation made in the working group report.  TOX/2014/30

5.  Scoping paper on the potential risks from polybrominated biphenyls (PBBs) in the infant diet. The COT has been asked to consider aspects related to the toxicity of chemicals in food, in support of a review by the Scientific Advisory Committee on Nutrition (SACN) of Government recommendations on complementary and young child feeding. This paper provides information on PBBs and asks COT to advise on the approach to be taken for this topic. TOX/2014/31

6. Second draft statement on the potential risks from polybrominated diphenyl ethers (PBDEs) in the infant diet. This draft COT statement summarises the available information and the Committee’s provisional conclusions.  TOX/2014/32

7. Second draft statement on adverse effects of high levels of vitamin D. At the request of the Department of Health, the SACN are revising the Dietary Reference Values (DRVs) for vitamin D and as part of this process the COT have been asked to consider the potential adverse effects of high vitamin D intakes. A revised draft of the final statement has been prepared, reflecting comments and suggestions made by the committee. TOX/2014/33

8. Second draft statement on domoic acid in King Scallops (pecten maximus). The COT was asked to consider the evidence that was available to support shucking (removal of the non-edible parts) as a scientifically robust and effective method for managing the health risks associated with Amnesic Shellfish Poison (ASP) toxins in King Scallops which is caused by the water-soluble cyclic amino acid domoic acid (DA). This draft COT statement summarises the available information and the Committee’s provisional conclusions.  TOX/2014/34

9. First draft statement on the potential risks from hexabromocyclododecanes (HBCDDs) in the infant diet. This draft COT statement summarises the available information and the Committee’s provisional conclusions. TOX/2014/35

10. Paper for information: COT response to the EFSA Consultation on a draft scientific opinion on the risks to public health related to the presence of acrylamide in food. TOX/2014/36

11. Paper for information: FSA Scientific Advisory Committees (SACs) update TOX/2014/37

12.Any other business

Date of next meeting – 9 December 2014, Conference Rooms 4 &5, Aviation House, 125 Kingsway, London WC2 6NH

Secretariat
October 2014

Minutes